<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Sarepta Therapeutics aderisce a un accordo di licenza con il Nationwide Children&#039;s Hospital per il programma di terapia genica con Galgt2	</title>
	<atom:link href="https://www.parentproject.it/2017/01/17/sarepta-therapeutics-aderisce-a-un-accordo-di-licenza-con-il-nationwide-childrens-hospital-per-il-programma-di-terapia-genica-con-galgt2/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.parentproject.it/2017/01/17/sarepta-therapeutics-aderisce-a-un-accordo-di-licenza-con-il-nationwide-childrens-hospital-per-il-programma-di-terapia-genica-con-galgt2/</link>
	<description>Insieme per fermare la Duchenne e la Becker</description>
	<lastBuildDate>Tue, 17 Jan 2017 17:02:07 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
